APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fungal Infection Diagnosis

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.

Selected research

Market Analysis & Forecast

Global Fungal Infection Diagnosis Market Analysis and Forecast 2026-2032

31 December 2025190 pages

Choose your research edition.

Industry ResearchFungal Infection Diagnosis Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Fungal Infection Diagnosis Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Fungal Infection Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fungal Infection Diagnosis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Fungal Infection Diagnosis Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients

At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.

ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, accounting for more than 90% in 2019.

Read the full market overview

Among the two types of products, the galactomannan experiment accounts for the largest proportion, and in 2019, it accounts for about 60% of the market. The downstream application markets for the diagnosis of fungal infections are mainly hospitals, laboratories and others. Among them, hospitals accounted for the largest proportion.

Report Includes

This report presents an overview of global market for Fungal Infection Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fungal Infection Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Fungal Infection Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fungal Infection Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fungal Infection Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fungal Infection Diagnosis revenue, projected growth trends, production technology, application and end-user industry.

Fungal Infection Diagnosis Segment by Company

ASSOCIATES OF CAPE COD

BioRad

IMMY

Beijing Jinshanchuan

Danna Biological

Zhanjiang A & C Biological Ltd.

Fungal Infection Diagnosis Segment by Type

Galactomannan Test

(1 to 3)-β-D-glucan Experiment

Fungal Infection Diagnosis Segment by Application

Hospital

Laboratory

Others

Fungal Infection Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Infection Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fungal Infection Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Infection Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Fungal Infection Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fungal Infection Diagnosis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fungal Infection Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Galactomannan Test Major Player Table 3. (1 to 3)-β-D-glucan Experiment Major Player Table 4. Global Fungal Infection Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Laboratory Major Player Table 7. Others Major Player Table 8. Fungal Infection Diagnosis Industry Trends Table 9. Fungal Infection Diagnosis Industry Drivers Table 10. Fungal Infection Diagnosis Industry Opportunities and Challenges Table 11. Fungal Infection Diagnosis Industry Restraints Table 12. Global Fungal Infection Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Fungal Infection Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Fungal Infection Diagnosis Market Share by Region (2021-2026) Table 15. Global Fungal Infection Diagnosis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Fungal Infection Diagnosis Market Share by Region (2027-2032) Table 17. Global Fungal Infection Diagnosis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Fungal Infection Diagnosis Revenue Market Share by Players (2021-2026) Table 19. Global Fungal Infection Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Fungal Infection Diagnosis Key Players Headquarters & Area Served Table 21. Global Fungal Infection Diagnosis Players, Product Type & Application Table 22. Global Fungal Infection Diagnosis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Fungal Infection Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Fungal Infection Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Fungal Infection Diagnosis Revenue Market Share by Type (2021-2026) Table 29. Global Fungal Infection Diagnosis Revenue Market Share by Type (2027-2032) Table 30. Global Fungal Infection Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Fungal Infection Diagnosis Revenue Market Share by Application (2021-2026) Table 34. Global Fungal Infection Diagnosis Revenue Market Share by Application (2027-2032) Table 35. ASSOCIATES OF CAPE COD Company Information Table 36. ASSOCIATES OF CAPE COD Business Overview Table 37. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio Table 39. ASSOCIATES OF CAPE COD Recent Development Table 40. BioRad Company Information Table 41. BioRad Business Overview Table 42. BioRad Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BioRad Fungal Infection Diagnosis Product Portfolio Table 44. BioRad Recent Development Table 45. IMMY Company Information Table 46. IMMY Business Overview Table 47. IMMY Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. IMMY Fungal Infection Diagnosis Product Portfolio Table 49. IMMY Recent Development Table 50. Beijing Jinshanchuan Company Information Table 51. Beijing Jinshanchuan Business Overview Table 52. Beijing Jinshanchuan Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio Table 54. Beijing Jinshanchuan Recent Development Table 55. Danna Biological Company Information Table 56. Danna Biological Business Overview Table 57. Danna Biological Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Danna Biological Fungal Infection Diagnosis Product Portfolio Table 59. Danna Biological Recent Development Table 60. Zhanjiang A & C Biological Ltd. Company Information Table 61. Zhanjiang A & C Biological Ltd. Business Overview Table 62. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio Table 64. Zhanjiang A & C Biological Ltd. Recent Development Table 65. North America Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 66. North America Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 67. North America Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Fungal Infection Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Fungal Infection Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 72. Europe Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 73. Europe Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 74. Europe Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 75. Europe Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 76. Europe Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Fungal Infection Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 78. Europe Fungal Infection Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 79. China Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 80. China Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 81. China Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 82. China Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 84. Asia Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 85. Asia Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 86. Asia Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Fungal Infection Diagnosis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Fungal Infection Diagnosis Revenue by Region (US$ Million) & (2021-2026) Table 89. Asia Fungal Infection Diagnosis Revenue by Region (US$ Million) & (2027-2032) Table 90. SAMEA Fungal Infection Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 91. SAMEA Fungal Infection Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 92. SAMEA Fungal Infection Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 93. SAMEA Fungal Infection Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 94. SAMEA Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. SAMEA Fungal Infection Diagnosis Revenue by Country (2021-2026) & (US$ Million) Table 96. SAMEA Fungal Infection Diagnosis Revenue by Country (US$ Million) & (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Fungal Infection Diagnosis Image Figure 2. Global Fungal Infection Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fungal Infection Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Galactomannan Test Image Figure 5. (1 to 3)-β-D-glucan Experiment Image Figure 6. Global Fungal Infection Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Fungal Infection Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Laboratory Image Figure 10. Others Image Figure 11. Global Fungal Infection Diagnosis Market Size (US$ Million) & (2021-2032) Figure 12. Global Fungal Infection Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Fungal Infection Diagnosis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Fungal Infection Diagnosis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Fungal Infection Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Fungal Infection Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Fungal Infection Diagnosis Revenue Market Share by Type (2021-2032) Figure 19. Global Fungal Infection Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Fungal Infection Diagnosis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Fungal Infection Diagnosis Revenue Market Share by Application (2021-2032) Figure 22. North America Fungal Infection Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Fungal Infection Diagnosis Revenue Share by Type (2021-2032) Figure 24. North America Fungal Infection Diagnosis Revenue Share by Application (2021-2032) Figure 25. North America Fungal Infection Diagnosis Revenue Share by Country (2021-2032) Figure 26. United States Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Fungal Infection Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Fungal Infection Diagnosis Revenue Share by Type (2021-2032) Figure 31. Europe Fungal Infection Diagnosis Revenue Share by Application (2021-2032) Figure 32. Europe Fungal Infection Diagnosis Revenue Share by Country (2021-2032) Figure 33. Germany Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Fungal Infection Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Fungal Infection Diagnosis Revenue Share by Type (2021-2032) Figure 43. China Fungal Infection Diagnosis Revenue Share by Application (2021-2032) Figure 44. Asia Fungal Infection Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Fungal Infection Diagnosis Revenue Share by Type (2021-2032) Figure 46. Asia Fungal Infection Diagnosis Revenue Share by Application (2021-2032) Figure 47. Asia Fungal Infection Diagnosis Revenue Share by Region (2021-2032) Figure 48. Japan Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Fungal Infection Diagnosis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Fungal Infection Diagnosis Revenue Share by Type (2021-2032) Figure 56. SAMEA Fungal Infection Diagnosis Revenue Share by Application (2021-2032) Figure 57. SAMEA Fungal Infection Diagnosis Revenue Share by Country (2021-2032) Figure 58. Brazil Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Galactomannan Test
  • (1 to 3)-β-D-glucan Experiment
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • ASSOCIATES OF CAPE COD
  • BioRad
  • IMMY
  • Beijing Jinshanchuan
  • Danna Biological
  • Zhanjiang A & C Biological Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fungal Infection Diagnosis Market by Type
  3. 1.2.1 Global Fungal Infection Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Galactomannan Test
  5. 1.2.3 (1 to 3)-β-D-glucan Experiment
  6. 1.3 Fungal Infection Diagnosis Market by Application
  7. 1.3.1 Global Fungal Infection Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Laboratory
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Fungal Infection Diagnosis Market Dynamics
  1. 2.1 Fungal Infection Diagnosis Industry Trends
  2. 2.2 Fungal Infection Diagnosis Industry Drivers
  3. 2.3 Fungal Infection Diagnosis Industry Opportunities and Challenges
  4. 2.4 Fungal Infection Diagnosis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Fungal Infection Diagnosis Market Perspective (2021-2032)
  2. 3.2 Global Fungal Infection Diagnosis Growth Trends by Region
  3. 3.2.1 Global Fungal Infection Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fungal Infection Diagnosis Market Size by Region (2021-2026)
  5. 3.2.3 Global Fungal Infection Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Fungal Infection Diagnosis Revenue by Players
  2. 4.1.1 Global Fungal Infection Diagnosis Revenue by Players (2021-2026)
  3. 4.1.2 Global Fungal Infection Diagnosis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Fungal Infection Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fungal Infection Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Fungal Infection Diagnosis Key Players Headquarters & Area Served
  7. 4.4 Global Fungal Infection Diagnosis Players, Product Type & Application
  8. 4.5 Global Fungal Infection Diagnosis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Fungal Infection Diagnosis Market CR5 and HHI
  11. 4.6.3 2025 Fungal Infection Diagnosis Tier 1, Tier 2, and Tier 3
5 Fungal Infection Diagnosis Market Size by Type
  1. 5.1 Global Fungal Infection Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 5.3 Global Fungal Infection Diagnosis Revenue Market Share by Type (2021-2032)
6 Fungal Infection Diagnosis Market Size by Application
  1. 6.1 Global Fungal Infection Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Fungal Infection Diagnosis Revenue by Application (2021-2032)
  3. 6.3 Global Fungal Infection Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ASSOCIATES OF CAPE COD
  2. 7.1.1 ASSOCIATES OF CAPE COD Company Information
  3. 7.1.2 ASSOCIATES OF CAPE COD Business Overview
  4. 7.1.3 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio
  6. 7.1.5 ASSOCIATES OF CAPE COD Recent Developments
  7. 7.2 BioRad
  8. 7.2.1 BioRad Company Information
  9. 7.2.2 BioRad Business Overview
  10. 7.2.3 BioRad Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioRad Fungal Infection Diagnosis Product Portfolio
  12. 7.2.5 BioRad Recent Developments
  13. 7.3 IMMY
  14. 7.3.1 IMMY Company Information
  15. 7.3.2 IMMY Business Overview
  16. 7.3.3 IMMY Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 IMMY Fungal Infection Diagnosis Product Portfolio
  18. 7.3.5 IMMY Recent Developments
  19. 7.4 Beijing Jinshanchuan
  20. 7.4.1 Beijing Jinshanchuan Company Information
  21. 7.4.2 Beijing Jinshanchuan Business Overview
  22. 7.4.3 Beijing Jinshanchuan Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio
  24. 7.4.5 Beijing Jinshanchuan Recent Developments
  25. 7.5 Danna Biological
  26. 7.5.1 Danna Biological Company Information
  27. 7.5.2 Danna Biological Business Overview
  28. 7.5.3 Danna Biological Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Danna Biological Fungal Infection Diagnosis Product Portfolio
  30. 7.5.5 Danna Biological Recent Developments
  31. 7.6 Zhanjiang A & C Biological Ltd.
  32. 7.6.1 Zhanjiang A & C Biological Ltd. Company Information
  33. 7.6.2 Zhanjiang A & C Biological Ltd. Business Overview
  34. 7.6.3 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio
  36. 7.6.5 Zhanjiang A & C Biological Ltd. Recent Developments
8 North America
  1. 8.1 North America Fungal Infection Diagnosis Revenue (2021-2032)
  2. 8.2 North America Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 8.2.1 North America Fungal Infection Diagnosis Revenue by Type (2021-2026)
  4. 8.2.2 North America Fungal Infection Diagnosis Revenue by Type (2027-2032)
  5. 8.3 North America Fungal Infection Diagnosis Revenue Share by Type (2021-2032)
  6. 8.4 North America Fungal Infection Diagnosis Revenue by Application (2021-2032)
  7. 8.4.1 North America Fungal Infection Diagnosis Revenue by Application (2021-2026)
  8. 8.4.2 North America Fungal Infection Diagnosis Revenue by Application (2027-2032)
  9. 8.5 North America Fungal Infection Diagnosis Revenue Share by Application (2021-2032)
  10. 8.6 North America Fungal Infection Diagnosis Revenue by Country
  11. 8.6.1 North America Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Fungal Infection Diagnosis Revenue by Country (2021-2026)
  13. 8.6.3 North America Fungal Infection Diagnosis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Fungal Infection Diagnosis Revenue (2021-2032)
  2. 9.2 Europe Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Fungal Infection Diagnosis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Fungal Infection Diagnosis Revenue by Type (2027-2032)
  5. 9.3 Europe Fungal Infection Diagnosis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Fungal Infection Diagnosis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Fungal Infection Diagnosis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Fungal Infection Diagnosis Revenue by Application (2027-2032)
  9. 9.5 Europe Fungal Infection Diagnosis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Fungal Infection Diagnosis Revenue by Country
  11. 9.6.1 Europe Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Fungal Infection Diagnosis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Fungal Infection Diagnosis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Fungal Infection Diagnosis Revenue (2021-2032)
  2. 10.2 China Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 10.2.1 China Fungal Infection Diagnosis Revenue by Type (2021-2026)
  4. 10.2.2 China Fungal Infection Diagnosis Revenue by Type (2027-2032)
  5. 10.3 China Fungal Infection Diagnosis Revenue Share by Type (2021-2032)
  6. 10.4 China Fungal Infection Diagnosis Revenue by Application (2021-2032)
  7. 10.4.1 China Fungal Infection Diagnosis Revenue by Application (2021-2026)
  8. 10.4.2 China Fungal Infection Diagnosis Revenue by Application (2027-2032)
  9. 10.5 China Fungal Infection Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fungal Infection Diagnosis Revenue (2021-2032)
  2. 11.2 Asia Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Fungal Infection Diagnosis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Fungal Infection Diagnosis Revenue by Type (2027-2032)
  5. 11.3 Asia Fungal Infection Diagnosis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Fungal Infection Diagnosis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Fungal Infection Diagnosis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Fungal Infection Diagnosis Revenue by Application (2027-2032)
  9. 11.5 Asia Fungal Infection Diagnosis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Fungal Infection Diagnosis Revenue by Country
  11. 11.6.1 Asia Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Fungal Infection Diagnosis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Fungal Infection Diagnosis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fungal Infection Diagnosis Revenue (2021-2032)
  2. 12.2 SAMEA Fungal Infection Diagnosis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Fungal Infection Diagnosis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Fungal Infection Diagnosis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Fungal Infection Diagnosis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Fungal Infection Diagnosis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Fungal Infection Diagnosis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Fungal Infection Diagnosis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Fungal Infection Diagnosis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Fungal Infection Diagnosis Revenue by Country
  11. 12.6.1 SAMEA Fungal Infection Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Fungal Infection Diagnosis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Fungal Infection Diagnosis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst